First National Bank & Trust Co. of Newtown Sells 200 Shares of The Cigna Group (NYSE:CI)

First National Bank & Trust Co. of Newtown cut its holdings in shares of The Cigna Group (NYSE:CI) by 11.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,477 shares of the health services provider’s stock after selling 200 shares during the quarter. First National Bank & Trust Co. of Newtown’s holdings in The Cigna Group were worth $442,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in CI. Axiom Financial Strategies LLC bought a new position in shares of The Cigna Group during the first quarter worth approximately $212,000. Fairfield Bush & CO. bought a new position in The Cigna Group in the first quarter valued at approximately $40,000. Cibc World Market Inc. increased its stake in The Cigna Group by 52.6% in the first quarter. Cibc World Market Inc. now owns 18,975 shares of the health services provider’s stock valued at $4,547,000 after acquiring an additional 6,538 shares during the last quarter. Vontobel Holding Ltd. increased its stake in The Cigna Group by 6.5% in the first quarter. Vontobel Holding Ltd. now owns 9,212 shares of the health services provider’s stock valued at $2,265,000 after acquiring an additional 566 shares during the last quarter. Finally, Sequoia Financial Advisors LLC increased its stake in The Cigna Group by 36.5% in the first quarter. Sequoia Financial Advisors LLC now owns 1,283 shares of the health services provider’s stock valued at $307,000 after acquiring an additional 343 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

The Cigna Group Trading Up 0.8 %

Shares of The Cigna Group stock traded up $2.83 during trading on Friday, reaching $351.61. The company’s stock had a trading volume of 504,917 shares, compared to its average volume of 1,591,538. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company has a market cap of $102.80 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.06 and a beta of 0.56. The firm’s 50-day moving average is $348.06 and its two-hundred day moving average is $315.03. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.25. The business had revenue of $51.15 billion during the quarter, compared to analysts’ expectations of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The firm’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.96 EPS. On average, sell-side analysts anticipate that The Cigna Group will post 28.36 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 21st. Stockholders of record on Wednesday, March 6th were given a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.59%. This is a boost from The Cigna Group’s previous quarterly dividend of $1.23. The ex-dividend date was Tuesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is currently 32.20%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CI shares. Barclays started coverage on shares of The Cigna Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price objective on the stock. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Royal Bank of Canada raised shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $327.00 to $354.00 in a research note on Monday, February 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $384.00 price objective on shares of The Cigna Group in a research note on Wednesday, April 10th. Finally, Wells Fargo & Company raised their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 6th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and a consensus price target of $362.14.

Insider Transactions at The Cigna Group

In other news, CEO David Cordani sold 31,209 shares of the firm’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the sale, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at approximately $123,618,339.18. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CEO David Cordani sold 31,209 shares of the firm’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the sale, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at approximately $123,618,339.18. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the completion of the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The disclosure for this sale can be found here. In the last ninety days, insiders sold 114,144 shares of company stock valued at $39,296,330. Company insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.